Tunable T1 and T2 contrast abilities of manganese-engineered iron oxide nanoparticles through size control.
about
Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular ImagingFacile integration of multiple magnetite nanoparticles for theranostics combining efficient MRI and thermal therapy.Microwave-assisted green synthesis of superparamagnetic nanoparticles using fruit peel extracts: surface engineering, T 2 relaxometry, and photodynamic treatment potentialA Novel Gd-DTPA-conjugated Poly(L-γ-glutamyl-glutamine)-paclitaxel Polymeric Delivery System for Tumor Theranostics.Enhanced magnetic resonance imaging and staining of cancer cells using ferrimagnetic H-ferritin nanoparticles with increasing core size.L-DOPA-Coated Manganese Oxide Nanoparticles as Dual MRI Contrast Agents and Drug-Delivery Vehicles.Enzyme-Controlled Intracellular Self-Assembly of (18)F Nanoparticles for Enhanced MicroPET Imaging of Tumor.Albumin-based nanoparticles loaded with hydrophobic gadolinium chelates as T1-T2 dual-mode contrast agents for accurate liver tumor imaging.Active-target T1-weighted MR Imaging of Tiny Hepatic Tumor via RGD Modified Ultra-small Fe3O4 Nanoprobes.Catechin tuned magnetism of Gd-doped orthovanadate through morphology as T1-T2 MRI contrast agents.Recent advances in magnetic nanoparticle-based multi-modal imaging.A facile route to core-shell nanoparticulate formation of arsenic trioxide for effective solid tumor treatment.Highly monodisperse low-magnetization magnetite nanocubes as simultaneous T(1)-T(2) MRI contrast agents.Europium-engineered iron oxide nanocubes with high T1 and T2 contrast abilities for MRI in living subjects.Probing T1-T2 interactions and their imaging implications through a thermally responsive nanoprobe.An ultrasmall and metabolizable PEGylated NaGdF4:Dy nanoprobe for high-performance T(1)/T(2)-weighted MR and CT multimodal imaging.Surface impact on nanoparticle-based magnetic resonance imaging contrast agents.T-T molecular magnetic resonance imaging of renal carcinoma cells based on nano-contrast agents
P2860
Q30851553-F9955DFD-503D-4FA3-A12D-6A46762BB72AQ30884196-A512DB4C-8865-406F-ADE8-740F6F99BC13Q31124745-3EBCBDDA-AA15-4F31-86B9-67056B629C8CQ33812462-A3339E26-B01E-4AAF-87E0-4BA364E2E088Q35298245-6F2A1C8B-13B2-408B-8CF7-B339F6CA143FQ35855865-49915167-FB6F-4528-BD67-3EB9E904BDE1Q35868860-E7AE18A7-8C1A-47F2-8BFE-49D26A862B06Q36314337-2D5C0DC5-BB90-4168-85F6-8D1C98EC923DQ37202282-B000ADBB-A249-4C09-8A70-48BF75BE8609Q37345592-E95D2060-3832-4827-8A30-5BFC876D226CQ38344555-DFD2D9BE-B63C-463D-B1B5-35C20BA2463CQ38796959-25ADC032-B6C5-4710-AC2B-FA17CC17A5CFQ38870993-50750DDC-0697-4EF5-A94D-BBBC499EC57AQ38895480-93E49149-A9E5-4CA7-B369-348A3ED9CC3EQ46327941-C0D97741-25A1-434D-A709-554BA11DE760Q50937749-1658BE50-2E8E-4EC2-91F7-26B99992FB3EQ55073008-CB077B76-858F-404A-A463-A90FDCF57DBAQ57181647-59F1B69B-0830-4F58-A589-C267884ED845
P2860
Tunable T1 and T2 contrast abilities of manganese-engineered iron oxide nanoparticles through size control.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Tunable T1 and T2 contrast abi ...... articles through size control.
@en
Tunable T1 and T2 contrast abi ...... articles through size control.
@nl
type
label
Tunable T1 and T2 contrast abi ...... articles through size control.
@en
Tunable T1 and T2 contrast abi ...... articles through size control.
@nl
prefLabel
Tunable T1 and T2 contrast abi ...... articles through size control.
@en
Tunable T1 and T2 contrast abi ...... articles through size control.
@nl
P2093
P2860
P356
P1433
P1476
Tunable T1 and T2 contrast abi ...... articles through size control.
@en
P2093
Guoming Huang
Jiahe Chen
Lijiao Yang
Xiaomin Wang
Xiaoqin Chi
Zhenghuan Zhao
Zhong Chen
P2860
P304
10404-10412
P356
10.1039/C4NR02680B
P407
P50
P577
2014-09-01T00:00:00Z